- AccurKardia's AccurECG™ Analysis System Receives FDA 510🔍
- Press Releases🔍
- GE Healthcare and Accuray Collaborate to Expand Access ...🔍
- Breast Cancer Treatments on the Radixact System🔍
- Q1 2022 Accuray Incorporated Earnings Call🔍
- Inari Medical's FlowTriever System Receives FDA 510🔍
- Prostate Cancer Treatment🔍
- accuray incorporated🔍
Accuray Receives 510
Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic ...
AccurKardia's AccurECG™ Analysis System Receives FDA 510(k ...
AccurKardia, a medical technology company delivering clinical-grade ECG interpretation software, announced today that its flagship product, ...
Press Releases | Accuray Incorporated - Investor Relations
Receives Omega's prestigious NorthFace ScoreBoard AwardSM for exceeding customer expectations SUNNYVALE, Calif. , ... 510(k) Clearance SUNNYVALE, Calif.
GE Healthcare and Accuray Collaborate to Expand Access ...
“In 2022 it is estimated that more than one million U.S. cancer patients will receive treatment with radiation therapy[1]*. This statistic ...
Breast Cancer Treatments on the Radixact System - Accuray
*VitalHold is 510(k) cleared and cleared for the EU market. Availability is ... Connect with Accuray to get the answers you need. Contact Us. Facebook-f ...
Q1 2022 Accuray Incorporated Earnings Call
... Accuray's President; and Brandy Green, Accuray's ... Synchrony for Radixact, we received 510(k) approval for VOLO™ Ultra, the latest Accuray ...
Inari Medical's FlowTriever System Receives FDA 510(k) Clearance ...
Inari Medical's FlowTriever System Receives FDA 510(k) Clearance for Treatment of Right Atrial Clot in Transit ... IRVINE, Calif., Jan. 08, 2021 ( ...
Prostate Cancer Treatment | Accuray
In 2001 the CyberKnife System received. 510(k) clearance from the FDA to treat anywhere in the body where radiation is indicated. Page 10. 10. What is an ...
... 510(k) or PMA for modifications during facility audits. We have modified aspects of our CyberKnife and TomoTherapy platforms since receiving regulatory ...
Q2 2022 Accuray Incorporated Earnings Call
At the ASTRO meeting, we successfully introduced VOLO Ultra treatment planning for the Radixact System. Since introduction, we've received 510(k) ...
Press Releases | Accuray Incorporated - Investor Relations
Accuray's CyberKnife(R) G4 System Receives Shonin Approval. Latest Advances in CyberKnife Radiosurgery Now Available in Japan SUNNYVALE, Calif., Aug 03, 2010 ...
Equipe de liderança da Accuray
Ali received a Master of Business Administration degree from the University ... GS has led the development and 510K Clearance of eight medical device ...
Q4 and FY23 Accuray Incorporated Earnings Call August 9, 2023
directly to Accuray's Investor Relations page at investors.accuray.com. ... I am also pleased to announce that we have received 510(k) approval ...
Press Releases | Accuray Incorporated - Investor Relations
... 510(k) Clearance SUNNYVALE, Calif. and BOSTON, Oct. Toggle Summary August 31, 2011, Accuray Launches New Organization for CyberKnife® and TomoTherapy® System ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
After a device receives 510(k) clearance or a PMA, any modification that ... We have obtained 510(k) clearance for the CyberKnife System for the ...
510(k) clearance for the CyberKnife System to provide treatment planning and ... After a device receives 510(k) clearance or a PMA approval, it may be ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
After a device receives 510(k) clearance or a PMA approval, any modification ... notification for modifications made to the operation of the CyberKnife System and ...
Accuray Reports Fiscal 2024 First Quarter Financial Results
... get back to their lives, faster. Accuray is headquartered in ... ** Cenos is 510(k) pending. The solution is not available for sale ...
... Accuray Incorporated. Form 10-K for the Fiscal Year Ended June 30, 2014. Filed ... 510(k) clearance. Some low risk devices are exempted from this ...
united states securities and exchange commission - form 10-q
goal of improving dose accuracy and treatment times as compared to conventional radiation therapy systems. Most recently, we received FDA 510(k) clearance ...